2024 연구성과 (7 / 286)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
WoS SCOPUS Document Type Document Title Abstract Authors Affiliation ResearcherID (WoS) AuthorsID (SCOPUS) Author Email(s) Journal Name JCR Abbreviation ISSN eISSN Volume Issue WoS Edition WoS Category JCR Year IF JCR (%) FWCI ⓘ FWCI Update Date WoS Citation SCOPUS Citation Keywords (WoS) KeywordsPlus (WoS) Keywords (SCOPUS) KeywordsPlus (SCOPUS) Language Publication Stage Publication Year Publication Date DOI JCR Link DOI Link WOS Link SCOPUS Link
○ ○ Review ⓘ A comprehensive review of the characterization, host interactions, and stabilization advancements on probiotics: Addressing the challenges in functional food diversification ⓘ The demand for functional food is rising in tandem with the prevalence of chronic diseases. Probiotics play a crucial role in functional food development, yet their ability to confer health benefits to the host remains a topic of debate according to Food and Agriculture Organization/World Health Organization requirements. The application of culturomics, innovative isolation techniques, within the realm of probiotics is increasingly deemed essential for fully harnessing the latent potential of microbial reservoirs. Nevertheless, its application remains confined predominantly to human fecal sources. Following the integration of probiogenomics, significant advancements have been made in the safety assessment of probiotics. However, the adoption of novel probiotic microorganisms has yet to match the requisite pace. Progress in research concerning host-probiotic interactions by employing omics technologies, particularly in animal models, is notable. Nonetheless, the comprehensive elucidation of mechanisms of action and human trial studies are lagging behind. Additionally, the viability of probiotics, spanning from their production as functional foods to their transit to the human colon, has markedly improved through encapsulation techniques. Nevertheless, opportunities for exploration persist regarding alternative coating materials and diverse encapsulation methodologies. Furthermore, there is a discernible transition in the domain of probiotic-based functional foods, shifting away from a primarily dairy-centric focus toward inclusion in a broader array of food categories. This comprehensive review addresses critical issues ranging from isolation sources and novel techniques to the final functional food developments. while doing so, it explores probiogenomics applications for probiotic characterization, investigations into host-probiotic interactions, and strategies for probiotic stabilization under harsh environmental conditions. ⓘ Fentie, Eskindir Getachew; Lim, Kyeongmo; Jeong, Minsoo; Shin, Jae-Ho ⓘ Kyungpook Natl Univ, NGS Ctr, Daegu, South Korea; Addis Ababa Sci & Technol Univ, Dept Chem Engn, Addis Ababa, Ethiopia; Kyungpook Natl Univ, Dept Appl Biosci, Daegu 41566, South Korea ⓘ Fentie, Eskindir/LIG-6089-2024; shin, Jaeho/K-6792-2013 ⓘ 57245844200; 57805008000; 57292954900; 57224125922 ⓘ jhshin@knu.ac.kr; ⓘ COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY ⓘ COMPR REV FOOD SCI F ⓘ 1541-4337 23 5 SCIE FOOD SCIENCE & TECHNOLOGY ⓘ 2024 14.1 1.4 0.74 2025-05-07 ⓘ 8 8 probiotics; culturomics; probiogenomics; encapsulation; functional-food ⓘ SACCHAROMYCES-CEREVISIAE; IN-VITRO; LACTOBACILLUS; MICROENCAPSULATION; VIABILITY; HEALTH; TECHNOLOGIES; MECHANISMS; PREBIOTICS; BACTERIA ⓘ culturomics; encapsulation; functional-food; probiogenomics; probiotics ⓘ Animals; Functional Food; Gastrointestinal Microbiome; Humans; Probiotics; Encapsulation; Food chemistry; Food ingredients; Probiotics; probiotic agent; Chronic disease; Culturomics; Food and agriculture organization's; Functionals; Health benefits; Hosts interactions; Isolation techniques; Probiogenomic; Probiotics; World Health Organization; animal; functional food; human; intestine flora; microbiology; Functional food ⓘ English 2024 2024-09 10.1111/1541-4337.13424 ⓘ 바로가기 바로가기 바로가기 바로가기
○ Meeting Abstract ⓘ Blood biomarker-aided cancer discrimination of screen-detected small lung nodule: The Cancer Signature Ensemble ⓘ ⓘ Jang, Seung Hun; Park, Ji Young; Kim, Young-Chul; Oh, Hyung-Joo; Park, Young Sik; Cho, Jaeyoung; Kim, Yeon Wook; Lee, Shin Yup; Yoon, Jung-Ki; Jeong, Seongmun; Kim, Hwang-Phill; Kim, Su Yeon; Kim, Tae-You ⓘ Hallym Univ, Sacred Heart Hosp, Anyang, South Korea; Chonnam Natl Univ, Med Sch, Gwangju, South Korea; CNU Hwasun Hosp, Gwangju, South Korea; Seoul Natl Univ Hosp, Seoul, South Korea; Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea; Kyungpook Natl Univ Hosp, Daegu, South Korea; Stanford Univ, Sch Med, Stanford, CA USA; IMBdx Inc, Seoul, South Korea ⓘ Kim, Yong-Joo/AAK-1840-2021; Park, Young Sik/MBG-1896-2025; Kim, Yeon/AAM-9025-2021 ⓘ ⓘ chestor@hallym.or.kr; ⓘ EUROPEAN RESPIRATORY JOURNAL ⓘ EUR RESPIR J ⓘ 0903-1936 1399-3003 64 SCIE RESPIRATORY SYSTEM ⓘ 2024 21 1.4 ⓘ 0 ⓘ ⓘ ⓘ ⓘ English 2024 2024-09 10.1183/13993003.congress-2024.oa4677 ⓘ 바로가기 바로가기 바로가기
○ ○ Article ⓘ Consideration of molecular weight-dependent high thermal resistance of end-capped-oligoimide based thermoset resins ⓘ Interest in thermosetting resins for polymer applications in extreme environments, such as aerospace, is increasing. The construction of oligoimide-based crosslinking systems has been the focus of considerable research over the past 30 years, but the analysis of chemical structure and molecular weight dependence has not been systematically performed. In this study, we established both theoretical and experimental frameworks by performing simulations based on a deep understanding of the crosslinking structure and conducted a systematic investigation of the properties of bulk specimens by synthesizing and preparing samples with various molecular weights. Theoretical investigations suggested clear differences and tendencies depending on molecular weight and crosslinking reaction pathways. Furthermore, experimental results showed excellent agreement with the simulations and clearly revealed the correlation between the molecular weights of pristine resin and thermal properties, such as glass transition and decomposition. In addition, we successfully obtained a thermosetting resin with superior thermal properties under optimized conditions, including a glass transition temperature exceeding 350 C-degrees and a decomposition temperature exceeding 570( degrees)C. ⓘ Hoang, Van-Kien; Bae, Kwak Jin; Oh, Yuna; Kwon, Woohyeon; Oh, Jihyun; Ku, Kyosun; Kim, Minju; Nam, Ki-Ho; Yu, Jaesang; Yeo, Hyeonuk ⓘ Kyungpook Natl Univ, Dept Nanosci & Nanotechnol, 80 Daehak Ro, Daegu 41566, South Korea; Korea Inst Sci & Technol KIST, Inst Adv Composite Mat, Composite Mat Applicat Res Ctr, Chudong Ro 92, Bongdong Eup 55324, Wanju Gun, South Korea; Kyungpook Natl Univ, Sch Appl Chem Engn, 80 Daehak Ro, Daegu 41566, South Korea; Kyungpook Natl Univ, Dept Chem Educ, 80 Daehak Ro, Daegu 41566, South Korea; Kyungpook Natl Univ, Adv Inst Water Ind, 80 Daehak Ro, Daegu 41566, South Korea; Kyungpook Natl Univ, Dept Text Syst Engn, 80 Daehak Ro, Daegu 41566, South Korea ⓘ Yeo, Hyeonuk/AHE-0397-2022; yeo, hyeonuk/G-7890-2017 ⓘ 58279883100; 57222624745; 57206717431; 59341091000; 59341192100; 57219781815; 57203466947; 55553181500; 36669801400; 55324816500 ⓘ jamesyu@kist.re.kr;yeo@knu.ac.kr; ⓘ POLYMER TESTING ⓘ POLYM TEST ⓘ 0142-9418 1873-2348 140 SCIE MATERIALS SCIENCE, CHARACTERIZATION & TESTING;POLYMER SCIENCE ⓘ 2024 6 1.4 0 2025-05-07 ⓘ 0 0 Thermoset; Imide; Thermal resistance; Curing; Molecular weight; MD simulation ⓘ CROSS-LINKING; POLYMER; POLYIMIDE; KINETICS; DENSITY; FILMS; EPOXY; MODEL ⓘ Curing; Imide; MD simulation; Molecular weight; Thermal resistance; Thermoset ⓘ Decomposition; Thermal modeling; Thermosets; Extreme environment; High thermal; Imide; MD simulation; Molecular weight dependent; Oligoimides; Polymer applications; Property; Thermal; Thermoset resin; Crosslinking ⓘ English 2024 2024-11 10.1016/j.polymertesting.2024.108599 ⓘ 바로가기 바로가기 바로가기 바로가기
○ ○ Review ⓘ Role of obesity-management medications before and after metabolic bariatric surgery: a systematic review ⓘ ⓘ Cohen, Ricardo, V; Park, Ji Yeon; Prager, Gerhard; Bueter, Marco; le Roux, Carel W.; Parmar, Chetan; Kermansaravi, Mohammad; Salminen, Paulina; Miras, Alexander D. ⓘ Hosp Alemao Oswaldo Cruz, Ctr Obes & Diabet, Rua Treze Maio,1-815 Torre D 1 Andar, BR-01327001 Sao Paulo, Brazil; Kyungpook Natl Univ, Sch Med, Dept Surg, Daegu, South Korea; Kyungpook Natl Univ, Dept Surg, Chilgok Hosp, Daegu, South Korea; Vienna Med Univ, Dept Gen Surg, Div Visceral Surg, Vienna, Austria; Univ Zurich, Univ Hosp Zurich, Dept Surg & Transplantat, Zurich, Switzerland; Univ Coll Dublin, Diabet Complicat Res Ctr, Dublin, Ireland; UCL, Whittington Hosp, Bariatr & Emergency Surg, London, England; Iran Univ Med Sci, Minimally Invas & Bariatr Surg, Hazrate Rasool Akram Hosp, Tehran, Iran; Univ Turku, Dept Surg, Turku, Finland; Turku Univ Hosp, Div Digest Surg & Urol, Turku, Finland; Ulster Univ, Sch Med, Derry, North Ireland ⓘ MIRAS, ALEXANDER/AAF-9119-2021; Cohen, Ricardo/F-2470-2014; Salminen, Paulina/ABB-8883-2020; Park, Ji Yeon/AAV-2471-2020; Kermansaravi, Mohammad/G-1154-2017 ⓘ 7404158104; 57196405216; 7004129794; 13407704900; 56962726600; 23061421500; 57192913150; 7003591097; 23028034500 ⓘ ricardo.cohen@haoc.com.br; ⓘ BRITISH JOURNAL OF SURGERY ⓘ BJS-BRIT J SURG ⓘ 0007-1323 1365-2168 111 12 SCIE SURGERY ⓘ 2024 8.8 1.4 1.86 2025-05-07 ⓘ 6 8 ⓘ WEIGHT-LOSS; 3.0 MG; REGAIN; LIRAGLUTIDE; EFFICACY; THERAPY; PROGRAM; IMPACT ⓘ ⓘ hemoglobin A1c; liraglutide; metformin; orlistat; phentermine; semaglutide; topiramate; albuminuria; bariatric surgery; body mass; body weight loss; drug therapy; gastric banding; gastroplasty; human; microalbuminuria; non insulin dependent diabetes mellitus; obesity; prospective study; randomized controlled trial (topic); Review; sleeve gastrectomy; systematic review; article; drug therapy; obesity management ⓘ English 2024 2024-11-29 10.1093/bjs/znae284 ⓘ 바로가기 바로가기 바로가기 바로가기
○ Meeting Abstract ⓘ Time-Dependent Analysis of Calcium Channel Blocker Usage and Risk of Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis: A Nationwide Cohort Study ⓘ ⓘ Jin, Jang Hye; Huh, Jin-Young; Kim, Jin-Ho; Jeong, Jihyeon; Park, Joo Hun; Kim, Jae Young; Choi, Won-Il ⓘ Inha Univ, Inha Univ Hosp, Coll Med, Dept Internal Med, Incheon, South Korea; Chung Ang Univ, Gwangmyeong Hosp, Dept Internal Med, Div Pulm Allergy & Crit Care Med, Gwangmyeong, South Korea; Hanyang Univ, Myongji Hosp, Dept Internal Med, Coll Med,Div Cardiol, Goyang, South Korea; Kyungpook Natl Univ, Dept Stat, Daegu, South Korea; Ajou Univ, Sch Med, Dept Pulm & Crit Care Med, Suwon, South Korea; Natl Hlth Insurance Serv Ilsan Hosp, Dept Internal Med, Goyang, South Korea; Hanyang Univ, Myongji Hosp, Dept Internal Med, Goyang, South Korea ⓘ Park, Joo/AAP-9425-2020 ⓘ ⓘ rose4359@gmail.com; ⓘ EUROPEAN RESPIRATORY JOURNAL ⓘ EUR RESPIR J ⓘ 0903-1936 1399-3003 64 SCIE RESPIRATORY SYSTEM ⓘ 2024 21 1.4 ⓘ 0 ⓘ ⓘ ⓘ ⓘ English 2024 2024-09 10.1183/13993003.congress-2024.pa5165 ⓘ 바로가기 바로가기 바로가기
○ ○ Article ⓘ Augmented neuromuscular transmission: bridging physical and cognitive practices through intrinsic hybrid nanogenerator-integrated confirmation analysis system ⓘ Computer-assisted smart neurotherapy (CASNuT) is an emerging technology used for psychiatric rehabilitation, neurological rehabilitation, and schizophrenia to improve treatment and clinical decision-making. Combined mental practice (cognitive control) and physical practice (bending fingers) were incorporated into the prepared CASNuT. It is constructed using the network of multifunctional piezo-tribo hybrid (PDMS/BCST) composite film-based intrinsic hybrid nanogenerators (which acts as a mechano-electric sensor for the smart gloves) and computation with the interfacing circuit/display devices. Successful integration of piezoelectric and triboelectric charges enhanced the intrinsic hybrid nanogenerator output (426 V, 1.72 mA/m2, and 368.66 mu W/m2 at 100 M ohm) and sensing properties. Next, it demonstrated rehabilitation treatment (via CASNuT) and smart medical assistance using a mechano-electric smart medical glove. Computer-aided or assisted therapy computes for better assistance and treatment. ⓘ Prasanna, Asokan Poorani Sathya; Anithkumar, Monunith; Alluri, Nagamalleswara Rao; Kim, Sang-Jae ⓘ Jeju Natl Univ, Fac Appl Energy Syst, Nanomat & Syst Lab, Major Mechatron Engn, Jeju 63243, South Korea; Jeju Natl Univ, Coll Engn, Nanomat & Syst Lab, Major Mech Syst Engn, Jeju 63243, South Korea; Jeju Natl Univ, Res Inst New Energy Ind RINEI, Jeju 63243, South Korea; Kyungpook Natl Univ, Dept Mat Sci & Met Engn, Daegu 41566, South Korea; Kyungpook Natl Univ, Res Inst Automot Parts & Mat, Daegu 41566, South Korea; Jeju Natl Univ, Green Hydrogen Glocal Leading Res Ctr gH2 RC, Jeju 63243, South Korea ⓘ ; Kim, Sang-Jae/S-4053-2019 ⓘ 57949257800; 57712751800; 56527074500; 22944436400 ⓘ sathyaprabakaran.94@gmail.com;monunith.a@gmail.com;alluri@knu.ac.kr;kimsangj@jejunu.ac.kr; ⓘ ADVANCED COMPOSITES AND HYBRID MATERIALS ⓘ ADV COMPOS HYBRID MA ⓘ 2522-0128 2522-0136 7 5 SCIE MATERIALS SCIENCE, COMPOSITES;NANOSCIENCE & NANOTECHNOLOGY ⓘ 2024 21.8 1.5 1.8 2025-05-07 ⓘ 5 5 Computer-assisted smart neurotherapy; Intrinsic hybrid nanogenerators; TENG; PENG ⓘ MENTAL PRACTICE ⓘ Computer-assisted smart neurotherapy; Intrinsic hybrid nanogenerators; PENG; TENG ⓘ Electrotherapeutics; Medical nanotechnology; Neurophysiology; Patient rehabilitation; Piezoelectric devices; Piezoelectricity; Analysis system; Computer assisted; Computer-assisted smart neurotherapy; Confirmation Analysis; Emerging technologies; Intrinsic hybrid nanogenerator; Nanogenerators; Neurotherapy; PENG; TENG; Nanocomposite films ⓘ English 2024 2024-10 10.1007/s42114-024-00967-7 ⓘ 바로가기 바로가기 바로가기 바로가기
○ ○ Article ⓘ Combustion-assisted low-temperature ZrO2/SnO2 films for high-performance flexible thin film transistors ⓘ We developed high-performance flexible oxide thin-film transistors (TFTs) using SnO2 semiconductor and high-k ZrO2 dielectric, both formed through combustion-assisted sol-gel processes. This method involves the exothermic reaction of fuels and oxidizers to produce high-quality oxide films without extensive external heating. The combustion ZrO2 films were revealed to have an amorphous structure with a higher proportion of oxygen corresponding to the oxide network, which contributes to the low leakage current and frequency-independent dielectric properties. The ZrO2/SnO2 TFTs fabricated on flexible substrates using combustion synthesis exhibited excellent electrical characteristics, including a field-effect mobility of 26.16 cm2/Vs, a subthreshold swing of 0.125 V/dec, and an on/off current ratio of 1.13 x 106 at a low operating voltage of 3 V. Furthermore, we demonstrated flexible ZrO2/SnO2 TFTs with robust mechanical stability, capable of withstanding 5000 cycles of bending tests at a bending radius of 2.5 mm, achieved by scaling down the device dimensions. ⓘ Jang, Bongho; Kim, Junil; Lee, Jieun; Park, Geuntae; Yang, Gyuwon; Jang, Jaewon; Kwon, Hyuk-Jun ⓘ DGIST, Dept Elect Engn & Comp Sci, Daegu, South Korea; Kyungpook Natl Univ, Sch Elect & Elect Engn, Daegu, South Korea; Kyungpook Natl Univ, Sch Elect Engn, Daegu, South Korea; DGIST, Convergence Res Adv Ctr Olfact, Daegu, South Korea ⓘ ⓘ 57194718232; 57219942345; 57201385153; 58497902900; 59402187400; 57194107504; 57298892000 ⓘ hj.kwon@dgist.ac.kr; ⓘ NPJ FLEXIBLE ELECTRONICS ⓘ NPJ FLEX ELECTRON ⓘ 2397-4621 8 1 SCIE ENGINEERING, ELECTRICAL & ELECTRONIC;MATERIALS SCIENCE, MULTIDISCIPLINARY ⓘ 2024 15.5 1.5 0 2025-05-07 ⓘ 0 0 ⓘ K GATE DIELECTRICS; LEAKAGE CURRENT; LAYER; FACILE; STRESS; GROWTH ⓘ ⓘ ⓘ English 2024 2024-11-02 10.1038/s41528-024-00362-8 ⓘ 바로가기 바로가기 바로가기 바로가기
○ Meeting Abstract ⓘ Completion of the First Phase of Registration: Baseline Characteristics and Epidemiology of Hemophilia in Korea from the Korean Bleeding Disorder Registry (KBDR) ⓘ ⓘ Han, Jung Woo; Baek, Hee Jo; Park, Young Shil; Park, Sangkyu; Yoo, Ki Young; Choi, Eun Jin; Kim, J. I. Yoon; Hahn, Seung Min; Ahn, Won Kee; Lee, Haewon; Kwon, Seung Yeon; Lyu, Chuhl Joo; Kim, Soon Ki ⓘ Yonsei Univ, Yonsei Univ Hlth Syst, Coll Med, Dept Pediat, Seoul, South Korea; Chonnam Natl Univ, Hwasun Hosp, Dept Pediat, Hwasun, South Korea; Kyung Hee Univ Hosp, Seoul, South Korea; Ulsan Univ Hosp, Ulsan, South Korea; Korean Hemophilia Fdn, Seoul Clin, Seoul, South Korea; Daegu Catholic Univ, Med Ctr, Dept Pediat, Daegu, South Korea; Kyungpook Natl Univ, Sch Med, Dept Pediat, Daegu, South Korea; Yonsei Univ, Yonsei Univ Hlth Syst, Coll Med, Dept Pediat, Seoul, South Korea; Inha Univ, Dept Pediat, Incheon, South Korea ⓘ ⓘ ⓘ ⓘ BLOOD ⓘ BLOOD ⓘ 0006-4971 1528-0020 144 SCIE HEMATOLOGY ⓘ 2024 23.1 1.5 ⓘ 0 ⓘ ⓘ ⓘ ⓘ English 2024 2024-11-05 10.1182/blood-2024-210109 ⓘ 바로가기 바로가기 바로가기
○ Meeting Abstract ⓘ Distinct Factors Influence on Complete Hematological Response Maintenance in Polycythemia Vera Patients Treated with Alfa-2b: From a Phase 2 in South Korea ⓘ ⓘ Lee, Sung-Eun; Yoon, Sung-Soo; Yang, Deok-Hwan; Lee, Gyeong Won; Yoon, Seug Yun; Sohn, Sang Kyun; Shin, Ho-Jin; Bae, Sung Hwa; Choi, Chul Won; Choi, Yunsuk; Cheong, June-won; Bang, Soo-Mee; Park, Joon Seong; Oh, Sukjoong; Park, Yong; Park, Young Hoon ⓘ Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Hematol, Seoul, South Korea; Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; Chonnam Natl Univ, Hwasun Hosp, Med Sch, Dept Internal Med, Jeollanam Do, South Korea; Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Gyeongsang Natl Univ Hosp, Dept Internal Med, Jinju 52727, South Korea; Soonchunhyang Univ Seoul Hosp, Dept Internal Med, Div Hematol & Med Oncol, Seoul, South Korea; Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, Daegu, South Korea; Pusan Natl Univ, Pusan Natl Univ Hosp, Sch Med, Div Hematol Oncol,Dept Internal Med,Sch Med, Busan, South Korea; Pusan Natl Univ, Pusan Natl Univ Hosp, Sch Med, Dept Hematol Oncol, Busan 602739, South Korea; Daegu Catholic Univ, Daegu Catholic Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea; Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul 138736, South Korea; Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med, Seoul, South Korea; Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; Ajou Univ, Sch Med, Dept Hematol Oncol, Suwon, South Korea; Hanyang Univ, Med Ctr, Seoul, South Korea; Korea Univ, Coll Med, Dept Internal Med, Div Hematol Oncol, Seoul, South Korea; Ewha Womans Univ, Mokdong Hosp, Seoul, South Korea ⓘ Lee, SangHun/GPW-6306-2022 ⓘ ⓘ ⓘ BLOOD ⓘ BLOOD ⓘ 0006-4971 1528-0020 144 SCIE HEMATOLOGY ⓘ 2024 23.1 1.5 ⓘ 0 ⓘ ⓘ ⓘ ⓘ English 2024 2024-11-05 10.1182/blood-2024-206881 ⓘ 바로가기 바로가기 바로가기
○ ○ Article ⓘ Effect of Evogliptin on the Progression of Aortic Valvular Calcification ⓘ BACKGROUND Medical therapy for aortic stenosis (AS) remains an elusive goal. OBJECTIVES This study sought to establish whether evogliptin, a dipeptidyl peptidase-4 inhibitor, could reduce AS progression. METHODS A total of 228 patients (age 67 +/- 11 years; 33% women) with AS were randomly assigned to receive placebo (n = 75), evogliptin 5 mg (n = 77), or evogliptin 10 mg (n = 76). The primary endpoint was the 96-week change in aortic valve calcium volume (AVCV) on computed tomography. Secondary endpoints included the 48-week change in active calcification volume measured using F-18-sodium fluoride positron emission tomography (F-18-NaF PET). RESULTS There were no significant differences in the 96-week changes in AVCV between evogliptin 5 mg and placebo (-5.27; 95% CI:-55.36 to 44.82; P = 0.84) or evogliptin 10 mg and placebo (-18.83; 95% CI:-32.43 to 70.10; P = 0.47). In the placebo group, the increase in AVCV between 48 weeks and 96 weeks was higher than that between baseline and 48 weeks (136 mm(3); 95% CI: 108-163 vs 102 mm(3); 95% CI: 75-129; P = 0.0485). This increasing trend in the second half of the study was suppressed in both evogliptin groups. The 48-week change in active calcification volume on F-18-NaF PET was significantly lower in both the evogliptin 5 mg (-1,325.6; 95% CI:-2,285.9 to-365.4; P = 0.008) and 10-mg groups (-1,582.2; 95% CI:-2,610.8 to-553.5; P = 0.0038) compared with the placebo group. CONCLUSIONS This exploratory study did not demonstrate the protective effect of evogliptin on AV calcification. Favorable F-18-NaF PET results and possible suppression of aortic valve calcification with longer medication use in the evogliptin groups suggest the need for larger confirmatory trials. (A Multicenter, Double-blind, Placebo-controlled, Stratified-randomized, Parallel, Therapeutic Exploratory Clinical Study to Evaluate the Efficacy and Safety of DA-1229 in Patients With Calcific Aortic Valve Disease; NCT04055883) (c) 2024 by the American College of Cardiology Foundation. ⓘ Song, Jae-Kwan; Lee, Sahmin; Kim, Yong-Jin; Kim, Hyung-Kwan; Ha, Jong-Won; Choi, Eui-Young; Park, Seung-Woo; Park, Sung-Ji; Park, Yong-Hyun; Park, Jae-Hyeong; Yang, Dong Heon; Kim, Kye Hun; Yang, Dong Hyun; Han, Sangwon; Chae, Sun Young; Lee, Ji Sung; Song, Jong-Min; Cho, Goo-Yeong ⓘ Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, 88,Olympic ro 43 gil, Seoul 05505, South Korea; Seoul Natl Univ Hosp, Div Cardiol, Seoul, South Korea; Yonsei Univ, Severance Hosp, Coll Med, Div Cardiol, Seoul, South Korea; Gangnam Severance Hosp, Div Cardiol, Seoul, South Korea; Samsung Med Ctr, Div Cardiol, Seoul, South Korea; Pusan Natl Univ, Yangsan Hosp, Div Cardiol, Busan, South Korea; Chungnam Natl Univ Hosp, Daejeon, South Korea; Kyungpook Natl Univ Hosp, Div Cardiol, Daegu, South Korea; Chonnam Natl Univ Hosp, Gwangju, South Korea; Asan Med Ctr, Dept Radiol, Seoul, South Korea; Asan Med Ctr, Dept Nucl Med, Seoul, South Korea; Eulji Univ, Sch Med, Uijeongbu Eulji Med Ctr, Dept Nucl Med, Uijongbu, South Korea; Univ Ulsan, Asan Inst Life Sci, Coll Med, Clin Res Ctr,Asam Med Ctr, Seoul, South Korea; Seoul Natl Univ, Bundang Hosp, Coll Med, Div Cardiol, Seongnam, South Korea ⓘ ; Kim, Hyung-Kwan/ITU-6159-2023; Kim, Yong/X-3329-2019; choi, sun ryoung/AGZ-1893-2022; Park, Jae-Hyeong/AAD-9015-2021; Ha, Jong/E-3893-2012 ⓘ 7404788117; 56080537100; 56080368900; 57020235200; 57965523300; 7402122078; 55176620800; 36017243100; 56339823900; 36063048400; 35277423400; 56150430800; 16177049100; 56461714400; 59803683800; 57212925539; 7404787185; 57811909300 ⓘ jksong@amc.seoul.kr; ⓘ JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY ⓘ J AM COLL CARDIOL ⓘ 0735-1097 1558-3597 84 12 SCIE CARDIAC & CARDIOVASCULAR SYSTEMS ⓘ 2024 22.3 1.5 2.72 2025-05-07 ⓘ 6 6 aortic stenosis; calcium signaling; computed tomography; evogliptin; positron emission tomography ⓘ POSITRON-EMISSION-TOMOGRAPHY; VALVE CALCIFICATION; STENOSIS PROGRESSION; DISEASE PROGRESSION; INHIBITOR; DA-1229 ⓘ aortic stenosis; calcium signaling; computed tomography; evogliptin; positron emission tomography ⓘ Aged; Aortic Valve; Aortic Valve Stenosis; Aortic Valve, Calcification of; Calcinosis; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; bisoprolol; evogliptin; fluoride; sodium fluoride; 4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one; dipeptidyl peptidase IV inhibitor; piperazine derivative; adult; Agatston score; aged; aortic pressure; aortic stenosis; aortic valve calcification; Article; calcification; chronic kidney failure; computer assisted tomography; coronary artery calcification; coronary artery calcium score; coronary artery disease; diastolic blood pressure; Doppler flowmetry; double blind procedure; echocardiography; estimated glomerular filtration rate; female; follow up; glucose blood level; heart rate; human; hypercholesterolemia; hypertension; major clinical study; male; positron emission tomography; prevalence; sensitivity analysis; systolic blood pressure; aortic valve; aortic valve stenosis; calcinosis; clinical trial; controlled study; diagnostic imaging; disease exacerbation; drug therapy; middle aged; multicenter study; pathology; procedures; randomized controlled trial; treatment outcome; x-ray computed tomography ⓘ English 2024 2024-09-17 10.1016/j.jacc.2024.06.037 ⓘ 바로가기 바로가기 바로가기 바로가기
○ Meeting Abstract ⓘ Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse ⓘ ⓘ Al-Shaibani, Eshrak; Cai, Yu; Song, Xianmin; Al Zahrani, Mohsen; Elemary, Mohamed; Alhumaid, Muhned; Alkhaldi, Hanan; Saad, Ayman; Bbiavasco, Francesc; Zeiser, Robert; Moon, Joon Ho; Sohn, Sang Kyun; Mattsson, Jonas; Kim, Dennis Dong Hwan ⓘ Princess Margaret Hosp, Hans Messner Allogene Transplant Program, Div Med Oncol & Hematol, Toronto, ON, Canada; Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Shanghai, Peoples R China; Minist Natl Guard Hlth Affairs, King Abdulaziz Med City, Riyadh, Saudi Arabia; Univ Saskatchewan, Prov Hematol & Blood & Marrow Transplant Program, Saskatchewan Canc Agcy, Saskatoon, SK, Canada; King Fahad Med City, Dept Hematol, Riyadh, Saudi Arabia; KFSHRC, Stem Cell Transplantat & Cellular Therapy, Dept Hematol, Riyadh, Saudi Arabia; Univ Freiburg, Med Ctr, Dept Med 1, Freiburg, Germany; Kyungpook Natl Univ Hosp, Daegu, South Korea ⓘ Alhumaid, Muhned/AHA-2993-2022; Zeiser, Robert/AEF-7995-2022 ⓘ ⓘ ⓘ BLOOD ⓘ BLOOD ⓘ 0006-4971 1528-0020 144 SCIE HEMATOLOGY ⓘ 2024 23.1 1.5 ⓘ 0 ⓘ ⓘ ⓘ ⓘ English 2024 2024-11-05 10.1182/blood-2024-211761 ⓘ 바로가기 바로가기 바로가기
○ Meeting Abstract ⓘ Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? ⓘ ⓘ Garcia-Horton, Alejandro; Ahmad, Imran; Lepic, Kylie; Lemieux, Christopher; Sanford, David; Elemary, Mohamed; Jamani, Kareem; Al Zahrani, Mohsen; Alhumaid, Muhned; Alotaibi, Ahmad S.; Saad, Ayman; Alhuraiji, Ahmad; Al-Khabori, Murtadha; Bazarbachi, Ali; Zeiser, Robert; Mehra, Varun; Ahn, Jae-Sook; Kim, Hyeoung-Joon; Moon, Joon Ho; Sohn, Sang Kyun; Cai, Yu; Song, Xianmin; Huang, Xiao Jun; Ye, Yishan; Huang, He; Kim, Hee-je; Kim, Dennis Dong Hwan ⓘ McMaster Univ, Juravinski Hosp, Dept Oncol, Ancaster, ON, Canada; McMaster Univ, Canc Ctr, Dept Oncol, Ancaster, ON, Canada; Hop Maison Neuve Rosemont, Montreal, PQ, Canada; McMaster Univ, Juravinski Hosp, Dept Oncol, Hamilton, ON, Canada; McMaster Univ, Canc Ctr, Dept Oncol, Hamilton, ON, Canada; CHU Quebec Univ Laval, Ctr Integre Cancerol, Quebec City, PQ, Canada; Univ British Columbia, British Columbia & Vancouver Gen Hosp, Dept Med, Leukemia Bone Marrow Transplant Program,Div Hemato, Vancouver, BC, Canada; Univ Saskatchewan, Prov Hematol & Blood & Marrow Transplant Program, Saskatchewan Canc Agcy, Saskatoon, SK, Canada; Univ Calgary, Tom Baker Canc Ctr, Cumming Sch Med, Calgary, AB, Canada; Minist Natl Guard Hlth Affairs, King Abdulaziz Med City, Riyadh, Saudi Arabia; King Fahad Med City, Dept Hematol, Riyadh, Saudi Arabia; King Faisal Specialist Hosp & Res Ctr, Canc Ctr Excellence, Dept Hematol Stem Cell Transplantat & Cellular The, Riyadh, Saudi Arabia; King Faisal Specialist Hosp & Res Ctr KFSHRC, Riyadh, Saudi Arabia; Kuwait Canc Ctr, Shuwaikh, Kuwait; Sultan Qaboos Univ, Muscat, Oman; Amer Univ Beirut, Dept Med, Beirut, Lebanon; Albert Ludwigs Univ ALU, Univ Freiburg, Fac Med, Freiburg, Germany; Kings Coll Hosp NHS Fdn Trust, Dept Haematol Med, London, England; Chonnam Natl Univ, Hwasun Hosp, Gwangju, Jeollanam Do, South Korea; Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea; Kyungpook Natl Univ Hosp, Daegu, South Korea; Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Shanghai, Peoples R China; Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Shanghai, Peoples R China; Peking Univ, Peoples Hosp, Beijing Key Lab Hematopoiet Stem Cell Transplantat, Natl Clin Res Ctr Hematol Dis,Inst Hematol, Beijing, Peoples R China; Zhejiang Univ, Afliated Hosp 1, Bone Marrow Transplantat Ctr, Sch Med, Hangzhou, Peoples R China; Zhejiang Univ, Afliated Hosp 1, Sch Med, Hangzhou, Peoples R China; Catholic Univ Korea, Seoul St Marys Hosp, Dept Hematol, Seoul, South Korea; Univ Hlth Network, Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada ⓘ Ye, Yishan/G-3886-2018; Alhumaid, Muhned/AHA-2993-2022; Garcia-Horton, Alejandro/AAE-4477-2021; Khabori, Murtadha/I-4774-2019; Mehra, Varun/AAS-1390-2020 ⓘ ⓘ ⓘ BLOOD ⓘ BLOOD ⓘ 0006-4971 1528-0020 144 SCIE HEMATOLOGY ⓘ 2024 23.1 1.5 ⓘ 0 ⓘ ⓘ ⓘ ⓘ English 2024 2024-11-05 10.1182/blood-2024-206153 ⓘ 바로가기 바로가기 바로가기
○ Meeting Abstract ⓘ Nationwide Analysis on Incidences and Treatment Outcomes of T-Cell Subtype Lymphomas Based on Health Insurance Review & Assessment Service ⓘ ⓘ Lee, Jungmin; Jang, Youngeun; Lee, Yunji; Cho, Hee Jeong; Moon, Joon Ho; Do, Young Rok; Sohn, Sang Kyun; Baek, Dong Won ⓘ Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, Daegu, South Korea; Keimyung Univ, Dongsan Med Ctr, Dept Hemato Oncol, Daegu, South Korea ⓘ ⓘ ⓘ ⓘ BLOOD ⓘ BLOOD ⓘ 0006-4971 1528-0020 144 SCIE HEMATOLOGY ⓘ 2024 23.1 1.5 ⓘ 0 ⓘ ⓘ ⓘ ⓘ English 2024 2024-11-05 10.1182/blood-2024-203187 ⓘ 바로가기 바로가기 바로가기
○ Meeting Abstract ⓘ Performance evaluation of the automated cell image analyzer DI-60 for leukocyte differential count ⓘ ⓘ Chang, S.; Kim, E.; Kim, Y.; Won, D. ⓘ Kyungpook Natl Univ Hosp, Daegu, South Korea ⓘ ⓘ ⓘ ⓘ CLINICAL CHEMISTRY ⓘ CLIN CHEM ⓘ 0009-9147 1530-8561 70 SCIE MEDICAL LABORATORY TECHNOLOGY ⓘ 2024 6.3 1.5 ⓘ 0 ⓘ ⓘ ⓘ ⓘ English 2024 2024-10 ⓘ 바로가기 바로가기
○ Meeting Abstract ⓘ Predicting Molecular Response through Half Reduction of Neutrophil-to-Lymphocyte Ratio (NLR) in Polycythemia Vera Treatment with Ropeginterferon ⓘ ⓘ Yoon, Seug Yun; Won, Jong-Ho; Lee, Sung-Eun; Yoon, Sung-Soo; Yang, Deok-Hwan; Lee, Gyeong Won; Sohn, Sang Kyun; Shin, Ho-Jin; Bae, Sung Hwa; Choi, Chul Won; Choi, Yunsuk; Cheong, June-won; Bang, Soo-Mee; Park, Joon Seong; Oh, Sukjoong; Park, Yong; Park, Young Hoon ⓘ Soonchunhyang Univ, Dept Internal Med, Div Hematol & Med Oncol, Seoul Hosp, Seoul, South Korea; Catholic Univ Korea, Coll Med, Seoul St Marys Hosp,Coll Med, Dept Hematol, Houston, TX USA; Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; Chonnam Natl Univ, Hwasun Hosp, Dept Hematol & Oncol, Hwasun, South Korea; Gyeongsang Natl Univ, Coll Med, Gyeongsang Natl Univ Hosp, Dept Internal Med, Jinju, South Korea; Kyungpook Natl Univ Hosp, Kyungpook Natl Univ, Sch Med, Dept Hematol Oncol, Daegu, South Korea; Pusan Natl Univ Hosp, Sch Med, Sch Med, Dept Internal Med,Div Hematol Oncol, Busan, South Korea; Daegu Catholic Univ, Univ Hosp, Dept Internal Med, Sch Med, Daegu 42472, South Korea; Korea Univ, Dept Internal Med, Coll Med, Seoul, South Korea; Univ Ulsan, Coll Med, Asan Med Ctr, Coll Med, Seoul 138736, South Korea; Yonsei Univ, Severance Hosp, Coll Med, Seoul, South Korea; Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; Ajou Univ, Sch Med, Dept Hematol Oncol, Suwon, South Korea; Hanyang Univ, Med Ctr, Seoul, South Korea; Korea Univ, Coll Med, Dept Internal Med, Div Hematol Oncol, Seoul, South Korea; Ewha Womans Univ, Mokdong Hosp, Seoul, South Korea ⓘ Won, Jongho/AAM-8322-2021; Lee, SangHun/GPW-6306-2022; PARK, JUN-YOUNG/AAW-5439-2021 ⓘ ⓘ ⓘ BLOOD ⓘ BLOOD ⓘ 0006-4971 1528-0020 144 SCIE HEMATOLOGY ⓘ 2024 23.1 1.5 ⓘ 0 ⓘ ⓘ ⓘ ⓘ English 2024 2024-11-05 10.1182/blood-2024-207042 ⓘ 바로가기 바로가기 바로가기
페이지 이동: